FAAS
KDNY

First Allied Advisory Services’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

First Allied Advisory Services’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$24K Hold
2,000
– – ﹤0.01% 1172
2020
Q2 		$23K Buy
+2,000
New +$27.6K ﹤0.01% 1099

Other funds holding KDNY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

First Allied Advisory Services's KDNY Position: Q3 2020 in Review

First Allied Advisory Services held its Chinook Therapeutics, Inc. Common Stock (KDNY) position steady in Q3 2020 at 2,000 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

First Allied Advisory Services first reported a position in KDNY in Q2 2020 and has held it in 2 quarters since. 70 funds tracked by Wall St. Rank hold KDNY as of Q3 2020.

  • First Allied Advisory Services held 2,000 shares of Chinook Therapeutics, Inc. Common Stock worth $24K as of Q3 2020.
  • First Allied Advisory Services left its Chinook Therapeutics, Inc. Common Stock share count unchanged in Q3 2020.
  • Chinook Therapeutics, Inc. Common Stock made up ﹤0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #1172 holding.
  • First Allied Advisory Services first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2020 and has held it in 2 quarters since.
  • 70 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.